Inventor · disambiguated record
Clay B. Siegall
Also filed as: SIEGALL CLAY · SIEGALL CLAY B
16 granted patents·5 pending applications·989 citations·filing 1991–2009
96Inventor score
Files withSEATTLE GENETICS INC12BRISTOL MYERS SQUIBB CO6BRISTOL MYERS SQUIBB1US AS REPRESENTED BY THE DEPAR1
Top patents by PatentIndex Score
21 records- 0197US7090843B1Recombinant anti-CD30 antibodies and uses thereofSEATTLE GENETICS INC·Filed 2000·Granted Aug 15, 2006·155 cites·18 claims
- 0296US7666422B2Methods for the treatment of cancer using anti-CD40 antibodiesSEATTLE GENETICS INC·Filed 2009·Granted Feb 23, 2010·30 cites·17 claims
- 0396US5932447ACloning and expression of a gene encoding bryodin 1 from Bryonia dioicaBRISTOL MYERS SQUIBB CO·Filed 1996·Granted Aug 3, 1999·144 cites·10 claims
- 0495US6843989B1Methods for the treatment and prevention of cancer using anti-CD40 antibodiesSEATTLE GENETICS INC·Filed 2000·Granted Jan 18, 2005·57 cites·78 claims
- 0595US6838261B1Nucleic acids encoding anti-CD40 proteins and methods of producing recombinant anti-CD40 proteinsSEATTLE GENETICS INC·Filed 2000·Granted Jan 4, 2005·61 cites·35 claims
- 0694US7824683B2Methods for augmenting an immune response using anti-CD40 antibodiesSEATTLE GENETICS INC·Filed 2009·Granted Nov 2, 2010·18 cites·14 claims
- 0793US6946129B1Recombinant anti-CD40 antibody and uses thereofSEATTLE GENETICS INC·Filed 1999·Granted Sep 20, 2005·70 cites·21 claims
- 0892US7510711B2Methods for the treatment of cancer using anti-CD40 antibodiesSEATTLE GENETICS INC·Filed 2005·Granted Mar 31, 2009·14 cites·8 claims
- 0992US5811098AAntibodies to HER4, human receptor tyrosine kinaseBRISTOL MYERS SQUIBB CO·Filed 1995·Granted Sep 22, 1998·123 cites·17 claims
- 1091US7498032B2Methods for treating immune disorders or cancer with anti-CD40 antibodiesSEATTLE GENETICS INC·Filed 2004·Granted Mar 3, 2009·28 cites·24 claims
- 1189US5980896AAntibodies reactive with human carcinomasBRISTOL MYERS SQUIBB CO·Filed 1993·Granted Nov 9, 1999·104 cites·35 claims
- 1286US5328984ARecombinant chimeric proteins deliverable across cellular membranes into cytosol of target cellsUS AS REPRESENTED BY THE DEPAR·Filed 1991·Granted Jul 12, 1994·87 cites·13 claims
- 1370US5597569ABryodin 2 a ribosome-inactivating protein isolated from the plant Bryonia dioicaBRISTOL MYERS SQUIBB CO·Filed 1994·Granted Jan 28, 1997·30 cites·41 claims
- 1466US5541110ACloning and expression of a gene encoding bryodin 1 from Bryonia dioicaBRISTOL MYERS SQUIBB·Filed 1994·Granted Jul 30, 1996·18 cites·11 claims
- 1566US2008213289A1Recombinant anti-cd30 antibodies and uses thereofSEATTLE GENETICS INC·Filed 2008·Application pending·0 cites
- 1665US5688781AMethod for treating vascular leak syndromeBRISTOL MYERS SQUIBB CO·Filed 1994·Granted Nov 18, 1997·28 cites·8 claims
- 1761US5736536AMethod for treating vascular leak syndromeBRISTOL MYERS SQUIBB CO·Filed 1997·Granted Apr 7, 1998·22 cites·9 claims
- 1860US2005008637A1Recombinant cells and transgenic organisms encoding anti-CD40 proteinsSEATTLE GENETICS INC·Filed 2004·Application pending·0 cites
- 1957US2008317747A1Recombinant anti-cd30 antibodies and uses thereofSEATTLE GENETICS INC·Filed 2008·Application pending·0 cites
- 2054US2007258987A1Recombinant Anti-Cd30 Antibodies and Uses ThereofSEATTLE GENETICS INC·Filed 2004·Application pending·0 cites
- 2149US2004018194A1Recombinant anti-CD30 antibodies and uses thereofFiled 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Clay B. Siegall files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →